Related Experiment Video
Updated: May 13, 2026
08:20
Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Development of a pediatric cariogenicity index
E Whitney Evans1, Catherine Hayes, Carole A Palmer
1Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA.
Journal of Public Health Dentistry
|March 16, 2013
Summary
A new liquid cariogenicity index effectively identified children with severe early childhood caries (S-ECC). This dietary assessment tool shows promise for identifying children at risk and guiding interventions for dental health.
Area of Science:
- Dental Public Health
- Pediatric Dentistry
- Nutrition Science
Background:
- Severe early childhood caries (S-ECC) is a significant public health concern affecting preschool-aged children.
- Dietary factors, particularly liquid intake, are implicated in caries development.
- Existing tools for assessing dietary cariogenicity may not adequately capture risks associated with liquid consumption.
Purpose of the Study:
- To develop novel food and liquid cariogenicity indices.
- To evaluate the utility of these indices in distinguishing between children with and without S-ECC.
- To identify dietary risk factors for early childhood caries.
Main Methods:
- Development of food and liquid cariogenicity indices.
- Application of indices to dietary data from a Food Frequency Questionnaire (FFQ) and a 24-hour recall (24HR).
- Analysis of data from a cohort of 454 children with S-ECC and 429 caries-free children.
Main Results:
- No significant difference in food cariogenicity scores between S-ECC and caries-free groups.
- Liquid cariogenicity scores were significantly higher in the S-ECC group compared to caries-free children (p < 0.001 for both FFQ and 24HR).
- Liquid cariogenicity score differentiated between groups and was associated with the number of carious lesions.
Conclusions:
- The developed liquid cariogenicity index demonstrates potential for research and clinical use.
- This index can aid in identifying modifiable dietary risk factors for caries in children.
- Further validation in clinical and public health settings is recommended.
Related Concept Videos
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...